347 related articles for article (PubMed ID: 29398083)
21. Haplotypes in the complement factor H (CFH) gene: associations with drusen and advanced age-related macular degeneration.
Francis PJ; Schultz DW; Hamon S; Ott J; Weleber RG; Klein ML
PLoS One; 2007 Nov; 2(11):e1197. PubMed ID: 18043728
[TBL] [Abstract][Full Text] [Related]
22. Increased circulating levels of Factor H-Related Protein 4 are strongly associated with age-related macular degeneration.
Cipriani V; Lorés-Motta L; He F; Fathalla D; Tilakaratna V; McHarg S; Bayatti N; Acar İE; Hoyng CB; Fauser S; Moore AT; Yates JRW; de Jong EK; Morgan BP; den Hollander AI; Bishop PN; Clark SJ
Nat Commun; 2020 Feb; 11(1):778. PubMed ID: 32034129
[TBL] [Abstract][Full Text] [Related]
23. Association of age-related macular degeneration with complement activation products, smoking, and single nucleotide polymorphisms in South Carolinians of European and African descent.
Rohrer B; Frazer-Abel A; Leonard A; Ratnapriya R; Ward T; Pietraszkiewicz A; O'Quinn E; Adams K; Swaroop A; Wolf BJ
Mol Vis; 2019; 25():79-92. PubMed ID: 30820144
[TBL] [Abstract][Full Text] [Related]
24. Role of the Complement System in Chronic Central Serous Chorioretinopathy: A Genome-Wide Association Study.
Schellevis RL; van Dijk EHC; Breukink MB; Altay L; Bakker B; Koeleman BPC; Kiemeney LA; Swinkels DW; Keunen JEE; Fauser S; Hoyng CB; den Hollander AI; Boon CJF; de Jong EK
JAMA Ophthalmol; 2018 Oct; 136(10):1128-1136. PubMed ID: 30073298
[TBL] [Abstract][Full Text] [Related]
25. Coding and noncoding variants in the CFH gene and cigarette smoking influence the risk of age-related macular degeneration in a Japanese population.
Mori K; Gehlbach PL; Kabasawa S; Kawasaki I; Oosaki M; Iizuka H; Katayama S; Awata T; Yoneya S
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5315-9. PubMed ID: 17962488
[TBL] [Abstract][Full Text] [Related]
26. Analysis of CFH, TLR4, and APOE polymorphism in India suggests the Tyr402His variant of CFH to be a global marker for age-related macular degeneration.
Kaur I; Hussain A; Hussain N; Das T; Pathangay A; Mathai A; Hussain A; Nutheti R; Nirmalan PK; Chakrabarti S
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3729-35. PubMed ID: 16936080
[TBL] [Abstract][Full Text] [Related]
27. Complement factor B polymorphism 32W protects against age-related macular degeneration.
Hughes AE; Mullan GM; Bradley DT
Mol Vis; 2011 Apr; 17():983-8. PubMed ID: 21541267
[TBL] [Abstract][Full Text] [Related]
28. Joint association of complement component 3 and CC-cytokine ligand2 (CCL2) or complement component 3 and CFH polymorphisms in age-related macular degeneration.
Bonyadi M; Jabbarpoor Bonyadi MH; Yaseri M; Mohammadian T; Fotouhi N; Javadzadeh A; Soheilian M
Ophthalmic Genet; 2017; 38(4):365-370. PubMed ID: 28095095
[TBL] [Abstract][Full Text] [Related]
29. A prospective assessment of the Y402H variant in complement factor H, genetic variants in C-reactive protein, and risk of age-related macular degeneration.
Schaumberg DA; Christen WG; Kozlowski P; Miller DT; Ridker PM; Zee RY
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2336-40. PubMed ID: 16723442
[TBL] [Abstract][Full Text] [Related]
30. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration.
Hageman GS; Anderson DH; Johnson LV; Hancox LS; Taiber AJ; Hardisty LI; Hageman JL; Stockman HA; Borchardt JD; Gehrs KM; Smith RJ; Silvestri G; Russell SR; Klaver CC; Barbazetto I; Chang S; Yannuzzi LA; Barile GR; Merriam JC; Smith RT; Olsh AK; Bergeron J; Zernant J; Merriam JE; Gold B; Dean M; Allikmets R
Proc Natl Acad Sci U S A; 2005 May; 102(20):7227-32. PubMed ID: 15870199
[TBL] [Abstract][Full Text] [Related]
31. Plasma levels of complement proteins from the alternative pathway in patients with age-related macular degeneration are independent of Complement Factor H Tyr⁴⁰²His polymorphism.
Silva AS; Teixeira AG; Bavia L; Lin F; Velletri R; Belfort R; Isaac L
Mol Vis; 2012; 18():2288-99. PubMed ID: 22969267
[TBL] [Abstract][Full Text] [Related]
32. Almost total protection from age-related macular degeneration by haplotypes of the Regulators of Complement Activation.
Williamson JF; McLure CA; Guymer RH; Baird PN; Millman J; Cantsilieris S; Dawkins RL
Genomics; 2011 Dec; 98(6):412-21. PubMed ID: 21855625
[TBL] [Abstract][Full Text] [Related]
33. Recurrent structural variation, clustered sites of selection, and disease risk for the complement factor H (
Cantsilieris S; Nelson BJ; Huddleston J; Baker C; Harshman L; Penewit K; Munson KM; Sorensen M; Welch AE; Dang V; Grassmann F; Richardson AJ; Guymer RH; Graves-Lindsay TA; Wilson RK; Weber BHF; Baird PN; Allikmets R; Eichler EE
Proc Natl Acad Sci U S A; 2018 May; 115(19):E4433-E4442. PubMed ID: 29686068
[TBL] [Abstract][Full Text] [Related]
34. Rare Variants in the Functional Domains of Complement Factor H Are Associated With Age-Related Macular Degeneration.
Triebwasser MP; Roberson ED; Yu Y; Schramm EC; Wagner EK; Raychaudhuri S; Seddon JM; Atkinson JP
Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6873-8. PubMed ID: 26501415
[TBL] [Abstract][Full Text] [Related]
35. The association between macular pigment optical density and CFH, ARMS2, C2/BF, and C3 genotype.
Loane E; Nolan JM; McKay GJ; Beatty S
Exp Eye Res; 2011 Nov; 93(5):592-8. PubMed ID: 21816153
[TBL] [Abstract][Full Text] [Related]
36. Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications.
Hageman GS; Hancox LS; Taiber AJ; Gehrs KM; Anderson DH; Johnson LV; Radeke MJ; Kavanagh D; Richards A; Atkinson J; Meri S; Bergeron J; Zernant J; Merriam J; Gold B; Allikmets R; Dean M;
Ann Med; 2006; 38(8):592-604. PubMed ID: 17438673
[TBL] [Abstract][Full Text] [Related]
37. Genome-wide association analyses of genetic, phenotypic, and environmental risks in the age-related eye disease study.
Ryu E; Fridley BL; Tosakulwong N; Bailey KR; Edwards AO
Mol Vis; 2010 Dec; 16():2811-21. PubMed ID: 21197116
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive analysis of CRP, CFH Y402H and environmental risk factors on risk of neovascular age-related macular degeneration.
Kim IK; Ji F; Morrison MA; Adams S; Zhang Q; Lane AM; Capone A; Dryja TP; Ott J; Miller JW; DeAngelis MM
Mol Vis; 2008 Aug; 14():1487-95. PubMed ID: 18704199
[TBL] [Abstract][Full Text] [Related]
39. Association between vitamin D status and age-related macular degeneration by genetic risk.
Millen AE; Meyers KJ; Liu Z; Engelman CD; Wallace RB; LeBlanc ES; Tinker LF; Iyengar SK; Robinson JG; Sarto GE; Mares JA
JAMA Ophthalmol; 2015 Oct; 133(10):1171-9. PubMed ID: 26312598
[TBL] [Abstract][Full Text] [Related]
40. Complement component C3 and risk of age-related macular degeneration.
Despriet DD; van Duijn CM; Oostra BA; Uitterlinden AG; Hofman A; Wright AF; ten Brink JB; Bakker A; de Jong PT; Vingerling JR; Bergen AA; Klaver CC
Ophthalmology; 2009 Mar; 116(3):474-480.e2. PubMed ID: 19168221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
